Mera is our Vice President in Genetics and Precision Immunology. She is an NIH/NHGRI-trained genetic epidemiologist and human geneticist. She leads Alumi’s efforts to leverage genomics and genetics to guide research and development of novel and precise therapeutics in collaboration with Foresite Labs. Mera previously did a stint in the start-up world leading the Precision Medicine and Translational Genetics group at Goldfinch Bio. Prior to Goldfinch, she spent six years at Pfizer in roles across drug discovery, development, and medical affairs. Prior to Pfizer, she was at the National Human Genome Research Institute, where she developed new methods for analyzing rare variants in DNA sequence data to discover novel genetic causes of coronary artery disease. During her early career she trained in a variety of fields, including molecular biology, bioinformatics, and science policy.
Sign up to view 0 direct reports
Get started